The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.
Yu Jo Chua
No relevant relationships to disclose
Christos Stelios Karapetis
No relevant relationships to disclose
Craig Underhill
No relevant relationships to disclose
Louise M. Nott
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Michelle F. Cronk
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose
Nicole Wong
No relevant relationships to disclose
Katrin Marie Sjoquist
No relevant relationships to disclose
Andrew Victor Biankin
No relevant relationships to disclose